资讯

MedPage Today on MSN13 小时
CDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV Shot
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
RSV vaccine access expanded to some people in their 50s, according to CDC website
In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to ...
CDC accepts RSV recommendations made by former vaccine panel
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
Kennedy Expands RSV Vaccine Recommendations. Moderna, Pfizer Shares Are Up.
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
US CDC accepts ousted vaccine panel's recommendations for RSV, meningococcal shots
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
CDC accepts former vaccine panel's RSV recommendations
The U.S. CDC recommends RSV vaccines for high-risk adults aged 50-59, endorsing the views of the former vaccine advisory ...
In surprise move, RFK Jr.'s vaccine committee votes to recommend RSV shot for infants
The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...
引起儿童呼吸道感染的HMPV 和 RSV，你能分清吗？
两种病毒的致病机制相似：病毒感染细支气管末端上皮细胞，导致细小支气管和细支气管直接损伤和炎症，引起细支气管炎。水肿、过量黏液和脱落的上皮细胞会导致细小气道阻塞和肺不张。
腾讯网6 天
牛津大学：两种疫苗联用可使痴呆风险下降37%
在全球阿尔茨海默病和其他痴呆症病例持续上升的背景下，一项来自牛津大学的重磅研究，疫苗或许为预防阿尔茨海默病等痴呆症开辟新的方向。 2025年6月25日，发表在《npj ...
BioSpace1 天
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...
RSV can cause severe disease for babies, this drug could prevent it
RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can ...
美国疾控中心专家组推荐默沙东集团的RSV预防药物用于婴儿
新泽西州拉威 - 美国疾病控制与预防中心免疫实践咨询委员会 (ACIP)已推荐默沙东集团 (NYSE: MRK )的ENFLONSIA作为预防选择，用于8个月以下、出生于或进入首个呼吸道合胞病毒 (RSV)季节的婴儿。这家市值1990亿美元、毛利率高达77%的制药巨头继续巩固其在医疗保健板块的地位。根据 InvestingPro ...